A Clinical Retrospective Database of Takotsubo Cardiomyopathy after Hemorrhagic Stroke: Assessing the Radiographic and Clinical Features Associated with Clinical Outcomes

A Clinical Retrospective Database of Takotsubo Cardiomyopathy after Hemorrhagic Stroke: Assessing the Radiographic and Clinical Features Associated with Clinical Outcomes - A Clinical Retrospective Database of Takotsubo Cardiomyopathy after Hemorrhagic Stroke: Assessing the Radiographic and Clinical Features Associated with Clinical Outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056190

Enrollment

Registered

2024-12-31

Start date

2024-11-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takotsubo Cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with hemorrhagic stroke (subarachnoid or intracerebral hemorrhage) and takotsubo cardiomyopathy who were hospitalized and treated in our department.

Exclusion criteria

Exclusion criteria: Patients who died prior to admission or who were denied participation by opt-out

Design outcomes

Primary

Measure	Time frame
Patients are classified as good prognosis (mRS 0-3) or poor prognosis (mRS 4-6) according to the modified Rankin Scale (mRS) score at discharge. Patient background such as age, gender, and medical history, severity of illness at presentation, various laboratory findings (CT, MRI, cerebral angiography, echo, blood tests, etc.), treatment details, surgical information, surgical and medical complications, and outcome will be reviewed.	—

Measure

Time frame

Patients are classified as good prognosis (mRS 0-3) or poor prognosis (mRS 4-6) according to the modified Rankin Scale (mRS) score at discharge. Patient background such as age, gender, and medical history, severity of illness at presentation, various laboratory findings (CT, MRI, cerebral angiography, echo, blood tests, etc.), treatment details, surgical information, surgical and medical complications, and outcome will be reviewed.

—

Countries

Japan

Contacts

Public ContactTomomichi Kayahara

Saitama Medical University International Medical Center Department of Cerebrovascular Surgery

t_kayahara@saitama-med.ac.jp+81-42-984-4111

Outcome results